Skip to main content
. 2018 Sep 10;13:47. doi: 10.1186/s13020-018-0205-x

Fig. 6.

Fig. 6

DOPA-1 treatment increases intracellular ROS production in HepG-2 cells. Data are presented as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ##p < 0.01, compared to the control